(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.78%.
Pepgen's earnings in 2026 is -$77,216,000.On average, 10 Wall Street analysts forecast PEPG's earnings for 2026 to be -$79,904,277, with the lowest PEPG earnings forecast at -$101,000,888, and the highest PEPG earnings forecast at -$69,722,569. On average, 10 Wall Street analysts forecast PEPG's earnings for 2027 to be -$85,873,580, with the lowest PEPG earnings forecast at -$145,061,678, and the highest PEPG earnings forecast at -$53,018,203.
In 2028, PEPG is forecast to generate -$77,082,173 in earnings, with the lowest earnings forecast at -$117,269,487 and the highest earnings forecast at -$58,828,417.